SEC Form 4 · accession 0000784199-18-000183
ARTIVION, INC. · AORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Capps
Officer — VP, Clinical Research
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000784199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | M | 8,332 | $5.67 | A | 147,419 | D | |
| Common StockF1 | Aug 30, 2018 | S | 6,332 | $34.10 | D | 141,087 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $5.67 | Aug 30, 2018 | M | 8,332 | D | Feb 18, 2013 | Feb 18, 2019 | Common Stock | 8,332 | 0 | D |
Explanation of responses
- F1Reflects weighted average price. Range was from $34.10 to $34.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F2Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/18/2013